This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of complex drug molecules. Its structure, featuring a trifluoromethylphenyl group, makes it valuable in the development of bioactive compounds, particularly those targeting specific enzymes or receptors. The presence of the carbamate group enhances its stability and bioavailability, making it suitable for use in prodrug formulations. Additionally, it is employed in research settings for studying enzyme inhibition mechanisms and exploring potential therapeutic applications in diseases such as cancer or inflammatory disorders. Its unique chemical properties also make it a candidate for use in asymmetric synthesis, aiding in the production of enantiomerically pure substances.